ESHG European Human Genetics Conference 2023

Visit us at booth #714

Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
10 July 2023
to 13 July 2023
SEC Glasgow
, Exhibition Way, Glasgow G3 8YW

About the event

The leading conference on human genetics in Europe.

Presenting at the event

Simultaneous measurement of genetics and epigenetics enables new biological insight ​

Robert Crawford

Associate Director, Customer Collaborations


Poster Presentation #P16.040.D ​

Presentation abstract

Dive deeper into how acquiring genetic and methylation data simultaneously produces higher quality calls that show how methylation promotes or silences specific alleles causing deregulation, altered expression, or potential disease.

Genetic and Epigenetic study of Formalin-damaged DNA

Fabio Puddu

Senior Bioinformatics Scientist


Session PV04 | Poster Presentation #P16.044.D

Presentation abstract

Review performance of duet multiomics solution +modC for the detection of genetic and epigenetic sequence data at base resolution when using formalin damaged DNA. Samples include formalin-compromised DNA standards (fcDNA) as well as DNA extracted from formalin-fixed and paraffin-embedded (FFPE) samples of two colorectal cancer (CRC) patients.

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

duet multiomics solution +modC

duet multiomics solution +modC

Gain complete genetic and epigenetic methylation information from your DNA library in a single workflow. All four genetic bases (A-C-G-T) without ambiguity in C or T calls – plus modified cytosine (modC) using your existing next-generation sequencing pipeline, phased within a single read.

Related resources

Attending from biomodal

Chief Executive Officer
Senior Director of Computational Technologies
Vice President, Global Marketing & Product Management

Get in touch

ESHG 2023
Cambridge Epigenetix is now biomodal